Type:Notice
Citation:86 FR 3197
Reading Time:less than a minute
Siemens Healthcare Diagnostics Inc. has submitted an application to the Drug Enforcement Administration to become a bulk manufacturer of certain controlled substances. The company intends to use these substances to produce products that are exempt from DEA regulations. Individuals or existing registered manufacturers can express their support or objections in writing by March 15, 2021, or request a hearing regarding this application by the same date.
Simple Explanation
Siemens Healthcare Diagnostics Inc. wants to make certain special medicines, and they have asked for permission from a group that checks if it's okay. People who have thoughts or worries about this can write to the group or ask to talk with them by March 15, 2021.